Ruxolitinib-loaded black phosphorus nanosheets actively target proximal tubule cells to ameliorate nephrotic syndrome by reducing inflammation and oxidative stress
Authors:
- 6 October 2022
- journal article
- research article
- Published by Elsevier in Nano Today
- Vol. 47, 101631
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Peptide–Drug Conjugate Linked via a Disulfide Bond for Kidney Targeted Drug DeliveryBioconjugate Chemistry, 2012
- Adriamycin nephropathy: A model of focal segmental glomerulosclerosisNephrology, 2010
- JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittinJournal of Inflammation, 2008
- Revised guidelines for management of steroid-sensitive nephrotic syndromeIndian Journal of Nephrology, 2008
- The Nephrotic Syndrome is an immunoinflammatory disorderMedical Hypotheses, 2007
- Mechanisms of H2O2-Induced Oxidative Stress in Endothelial Cells Exposed to Physiologic Shear StressASAIO Journal, 2007
- L‐carnitine ameliorates doxorubicin‐induced nephrotic syndrome in ratsNephrology, 2006
- Kidneys with heavy proteinuria show fibrosis, inflammation, and oxidative stress, but no tubular phenotypic changeKidney International, 2005
- Increased glomerular and extracellular malondialdehyde levels in patients and rats with focal segmental glomerulosclerosisEuropean Journal of Clinical Investigation, 2005
- Adriamycin-induced nephropathy as a model of chronic progressive glomerular diseaseKidney International, 1986